We are live on ! Find out more
TDC

Thompson Davis & Co Portfolio holdings

AUM $150M
1-Year Est. Return 32.35%
This Fund
S&P 500
This Quarter Est. Return
+11.83%
1 Year Est. Return
+32.35%
3 Year Est. Return
+199.51%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$42.2M
AUM Growth
-$14.3M
Cap. Flow
-$17.4M
Cap. Flow %
-41.13%
Top 10 Hldgs %
21.94%
Holding
1,277
New
146
Increased
131
Reduced
218
Closed
593

Top Buys

Rank Stock Value
1
VBR icon
Vanguard Small-Cap Value ETF
VBR
+$601K
2
KNSL icon
Kinsale Capital Group
KNSL
+$335K
3
PXLW icon
Pixelworks
PXLW
+$273K
4
GM icon
General Motors
GM
+$255K
5
MITL
Mitel Networks Corporation
MITL
+$250K

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$623K
2
INTC icon
Intel
INTC
+$608K
3
BAC icon
Bank of America
BAC
+$558K
4
AAPL icon
Apple
AAPL
+$527K
5
FDC
First Data Corporation
FDC
+$384K

Sector Composition

Rank Sector Weight
1 Technology 18.91%
2 Financials 9.93%
3 Healthcare 9.91%
4 Industrials 9.33%
5 Consumer Discretionary 7.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LULU icon
901
lululemon athletica
LULU
$13B
– –
-42
Closed -$3K
LYB icon
902
LyondellBasell Industries
LYB
$19.5B
– –
-38
Closed -$4K
MAT icon
903
Mattel
MAT
$4.17B
– –
-104
Closed -$2K
MCHP icon
904
Microchip Technology
MCHP
$42.8B
– –
-284
Closed -$13K
MCK icon
905
McKesson
MCK
$98.5B
– –
-117
Closed -$18K
MD icon
906
Pediatrix Medical
MD
$2.16B
– –
-1,053
Closed -$45K
MDLZ icon
907
Mondelez International
MDLZ
$77.7B
– –
-5,655
Closed -$230K
MDT icon
908
Medtronic
MDT
$107B
– –
-768
Closed -$60K
MDXG icon
909
MiMedx Group
MDXG
$626M
– –
-1,500
Closed -$18K
MET icon
910
MetLife
MET
$61B
– –
-139
Closed -$7K
MGIC
911
DELISTED
Magic Software Enterprises
MGIC
– –
-2,799
Closed -$24K
MGM icon
912
MGM Resorts International
MGM
$11.7B
– –
-346
Closed -$11K
MHK icon
913
Mohawk Industries
MHK
$6.9B
– –
-24
Closed -$6K
MHO icon
914
M/I Homes
MHO
$3.83B
– –
-3,679
Closed -$98K
MLKN icon
915
MillerKnoll
MLKN
$1.5B
– –
-200
Closed -$7K
MRSH
916
Marsh
MRSH
$86.3B
– –
-83
Closed -$7K
MMS icon
917
Maximus
MMS
$3.14B
– –
-520
Closed -$34K
MNST icon
918
Monster Beverage
MNST
$91.4B
– –
-450
Closed -$12K
MO icon
919
Altria Group
MO
$122B
– –
-254
Closed -$16K
MOG.A icon
920
Moog Inc Class A
MOG.A
$13B
– –
-381
Closed -$32K
MOH icon
921
Molina Healthcare
MOH
$10.3B
– –
-355
Closed -$24K
MPC icon
922
Marathon Petroleum
MPC
$90.3B
– –
-57
Closed -$3K
MPLX icon
923
MPLX
MPLX
$59.5B
– –
-218
Closed -$8K
MPWR icon
924
Monolithic Power Systems
MPWR
$65.5B
– –
-558
Closed -$59K
MPT
925
Medical Properties Trust
MPT
$2.89B
– –
-1,743
Closed -$23K
35 36
37
38 39

Similar funds

PAYA
Phil A. Younker & Associates Fairbanks, Alaska $150M AUM 9.85% 1-Year Est. Return
PCMNC
Piedmont Capital Management (North Carolina) Greensboro, North Carolina $150M AUM
LA
Lakeside Advisors Seattle, Washington $150M AUM 14.73% 1-Year Est. Return
MPW
Magnolia Private Wealth Philadelphia, Pennsylvania $150M AUM 18.29% 1-Year Est. Return
GWA
Genesis Wealth Advisors Braintree, Massachusetts $150M AUM 15.35% 1-Year Est. Return
GA
Gordian Advisors Tucson, Arizona $150M AUM 15.35% 1-Year Est. Return
RPA
Redwood Park Advisors Redwood City, California $150M AUM 11.34% 1-Year Est. Return
E
Evansbrook Bolingbrook, Illinois $150M AUM

Thompson Davis & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Thompson Davis & Co held 1,277 positions worth $42.2M, down 25% from $56.5M the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Thompson Davis & Co withdrew a net $17.4M in Q4 2017, closing 593 positions and reducing 218 holdings. Its most notable exit was Antares Pharma, Inc., an estimated $365K position sold in full.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Thompson Davis & Co opened a new position in General Motors worth $241K.

  • Thompson Davis & Co's largest Q4 2017 buy was General Motors: 5,878 shares worth $241K.
  • Thompson Davis & Co added most to Vanguard Small-Cap Value ETF in Q4 2017, an estimated $601K increase.
  • Thompson Davis & Co's biggest Q4 2017 reduction was JPMorgan Chase, cutting an estimated $623K.
  • Thompson Davis & Co fully exited Antares Pharma, Inc. in Q4 2017, selling an estimated $365K.
  • Thompson Davis & Co's ten largest holdings make up 22% of its $42.2M portfolio in Q4 2017.
  • Thompson Davis & Co opened 146 new positions and closed 593 in Q4 2017.
  • Thompson Davis & Co's portfolio value fell 25% quarter-over-quarter to $42.2M.

Based on Thompson Davis & Co's 13F filing for Q4 2017, filed 5 Feb 2018.